Navigation Links
Dr Steven Gillis to Join Shire Board of Directors
Date:9/4/2012

DUBLIN, Ireland, September 4, 2012 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Dr. Steven Gillis, Ph.D. will join the Board of Directors on October 1, 2012.  On joining the Board, Dr. Gillis will become a member of the Company's Science & Technology Committee and Remuneration Committee.

Dr. Gillis is currently a Managing Director at ARCH Venture Partners, a provider of venture capital for technology firms, where he is focused on the evaluation of new life science technologies and the development and growth of ARCH's biotechnology portfolio companies.  Prior to this, Dr. Gillis was a founder and director of Corixa Corporation, acquired by GlaxoSmithKline in 2005. Prior to starting Corixa, Dr. Gillis was a founder and director of Immunex Corporation.

An immunologist by training, Dr. Gillis has authored more than 300 peer-reviewed publications in the areas of molecular and tumor immunology. He is credited as being a pioneer in the field of cytokines and cytokine receptors, directing the development of multiple marketed products including Leukine, (GM-CSF), Prokine (IL-2) and Enbrel (soluble TNF receptor-Fc fusion protein) as well as the regulatory approval of Bexxar (radiolabeled anti-CD20) and the novel vaccine adjuvant, MPL.

He received his B.A. from Williams College in 1975 and his Ph.D. from Dartmouth College in 1978.

Dr. Gillis is a Non-Executive Director of Genesis Research and Development Corporation Limited., a New Zealand and Australian Stock Exchange-listed biotechnology company. He was a Non- Executive Director and then Executive Chairman and Acting President of Trubion Pharmaceuticals Inc., until its sale in 2010.

Shire Chairman, Matt Emmens, comments:

"Steven's pioneering and entrepreneurial approach paired with a deep technical and scientific knowledge will complement the existing skills
'/>"/>

SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
3. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
4. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
5. Shire Second Quarter Product Sales Up 16%
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Angeion Selects Hendrik Struik for Board of Directors
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
10. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
11. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® extracorporeal cytokine adsorber to purify ... of Dr. Joerg Scheier , M.D. as ... is a specialist in intensive care medicine and ... experience in treating critically-ill patients and in the ...
(Date:4/27/2015)... BRH Medical, Ltd., today announced ... Notification Application (510k) with the US Food and Drug ... Medical expects feedback from the FDA during the next ... following FDA pre-market clearance. Additional pre-market regulatory filings are ... CEO for BRH Medical, commented, "We are thrilled to ...
(Date:4/27/2015)... 2015 BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues ("BioLife" or ... and Drug Administration has confirmed acceptance of the Company,s ... not an endorsement nor approval of BioLife,s products for ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 2CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 4CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 5BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 2BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 3BioLife Solutions Submits FDA Master Files for Cell Thawing Media Products 4
... - 12-week study concludes that new cosmeceutical improves skin ... Calif., May 4 Senetek PLC (OTC ... the development of technologies that target the science of ... "Topical PRK-124 (0.125%) Lotion for Improving the Signs and ...
... Experience Significant Improvement in Ocular Surface Disease and Quality ... Inc. announced today that results from a large (n ... ophthalmic insert will be presented this week during the ... Vision and Ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, ...
Cached Medicine Technology:Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 2ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 3ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 4ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; 5
(Date:4/27/2015)... April 27, 2015 The Doctors on ... connect clients of personal injury attorneys with the best doctors ... has seen steady growth throughout their history and that trend ... DC and his team in the Tujunga / ... doctor and massage therapist, patients can find comprehensive care and ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Data Integrity ... Within Your Operations or Your Partners/Suppliers, **FDAnews Webinar**, May ... http://www.fdanews.com/DataIntegrity , Data integrity issues have become ... few years., Uncovering data integrity issues within manufacturing operations ... integrity issues come to light, remediating them can be ...
(Date:4/27/2015)... Como, Italy (PRWEB) April 27, 2015 ... that the design project SMRT IMAGE Lumica by Boombang ... of the Platinum A' Design Award in Scientific Instruments, ... Category. , Insights on SMRT IMAGE Lumica, Boombang Inc ... Product work SMRT IMAGE Lumica explained “SMRT Image Lumica ...
(Date:4/27/2015)... Telematics Berlin is Europe’s biggest Automotive ... CE players and the government to discuss the opportunities ... car. This year’s panel on connected car security with ... Commission, is an opportunity to hear and contribute towards ... Automotive Security Standard for years to come. , ...
(Date:4/27/2015)... Attorney Dan Newlin, of the Law ... his clients, took that commitment to a whole new level ... makes it easier for existing and potential clients to contact ... brand and added value to the firm’s services, #Dan covers ... Newlin has law offices. , “I knew the pound sign ...
Breaking Medicine News(10 mins):Health News:Prominent Doctors with Distinguished Backgrounds Join Doctors on Liens in Tujunga 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Dan Newlin Hashtags It With #Dan 2
... healthy crackle in the air! We have just been chipped in ... – chips! Wipe away that guilt// and let yourself have a ... complete range of McCain’s frozen chips has received the ‘green-signal’ from ... fat and saturated fat. The agency has accorded this brand of ...
... hundred villages in India will soon be well equipped ... centers - with the active involvement// of Indian American ... we would promote better hygiene, clean drinking water and ... also be given to creating awareness about vector borne ...
... with gonorrhea is probably twice as likely to develop bladder ... results in the British Journal of Cancer, lead author David ... the statement based on case studies of around 51,000 American ... men suffering from gonorrhea. Results analyzed showed that ...
... specially grown soy beans may prove to be successful ... says Tulane //University cancer researcher Matthew Burow. ... with ovarian and breast cancer tumors that are stimulated ... further growth of the tumors by interfering with the ...
... "gold-standard" amongst researchers for scientific studies. On the one ... has also questioned the worth of allopathic medicine practices, ... medicine (CAM) practices. Majority of CAM practices are difficult, ... ,The question arises as to whether EBM principles are ...
... blood thinning drugs quintupled during the 1990s, according to a ... than tenfold. ,Most of the increase is due ... prescribed to prevent blood clotting. Blood clots can lead to ... brain hemorrhage is a stroke caused by bleeding in the ...
Cached Medicine News:Health News:Better Healthcare for 100 Villages - Courtesy Indian American Physicians 2Health News:Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine? 2
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: